Anovulation and secondary amenorrhea: easy and practical approach

Anovulación y amenorrea secundaria: enfoque fácil y práctico;
Anovulação e amenorreia secundária: abordagem fácil e prática

dc.creatorPérez Agudelo, Luis Ernesto
dc.date2021-06-04
dc.date2023-03-22T19:09:44Z
dc.date2023-03-22T19:09:44Z
dc.date.accessioned2023-09-06T17:59:21Z
dc.date.available2023-09-06T17:59:21Z
dc.identifierhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/4853
dc.identifier10.18359/rmed.4853
dc.identifierhttp://hdl.handle.net/10654/43509
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8693733
dc.descriptionAnovulation occurs in 30 % of infertility and secondary amenorrhea in 4 % of women in reproductive age. Both alterations can become chronic, carrying risks of chronic hyperestrogenism and hypoestrogenism. Both anovulation and secondary amenorrhea have the same endocrine causes, except that amenorrhea has an additional uterine cause. However, there are many etiological classifications, some combine secondary and primary amenorrhea, others focus more on anovulation and some group the etiologies into compartments, without achieving a comprehensive approach. The objective is to review the etiological classifications of anovulation and secondary amenorrhea, together with the update of each one of these causes, in order to select the classification that can integrally groups them so that to their management can be focused on an easy and practical way. For this purpose, recent medical literature in textbooks, PubMed, Ovid, Clinical guidelines and Cochrane library was reviewed with key words. It is concluded that the comprehensive etiological classification in five compartments is an easy guide to follow to achieve the diagnosis of each of these causes, currently, when there are drugs and safe surgical procedures to manage them as anovulation or secondary amenorrhea.
dc.descriptionLa anovulación ocurre en el 30 % de la infertilidad y la amenorrea secundaria en el 4 % de mujeres en edad reproductiva. Ambas alteraciones se pueden tornar crónicas conllevando riesgos de hiperestrogenismo e hipoestrogenismo crónicos. Tanto la anovulación como la amenorrea secundaria tienen las mismas causas endocrinas, excepto que la amenorrea tiene una adicional de causa uterina. No obstante existen muchas clasificaciones etiológicas, unas combinan la amenorrea secundaria con la primaria, otras se enfocan más a la anovulación y algunas agrupan las etiologías en compartimentos, sin lograr hacerlo en forma integral. El objetivo es revisar las clasificaciones etiológicas de anovulación y amenorrea secundaria, junto con la actualización de cada una de esas causas, a fin de seleccionar la clasificación que las agrupe integralmente para enfocar el manejo en forma fácil y práctica. Para ello, se revisó la literatura médica reciente en libros de texto, PubMed, Ovid, Clinical guidelines y Cochrane library, con palabras claves. Se concluye que la clasificación etiológica integral en cinco compartimentos es una guía fácil de seguir, para lograr el diagnóstico de cada una de esas causas, actualmente, cuando existen medicamentos y procedimientos quirúrgicos seguros para manejarlas como anovulación o como amenorrea secundaria.
dc.descriptionA anovulação ocorre em 30 % da infertilidade e a amenorreia secundária em 4 % de mulheres em idade reprodutiva. Ambas as alterações podem se tornar crônicas, implicando riscos de hiperestrogenismo e hipoestrogenismo crônicos. Tanto a anovulação quanto a amenorreia secundária têm as mesmas causas endócrinas, exceto que esta última tem ainda causa uterina. Contudo, existem muitas classificações etiológicas, umas combinam a amenorreia secundária com a primária, outras se focam mais na anovulação, e algumas agrupam as etiologias em compartimentos sem poder fazer isso de forma integral. O objetivo é revisar as classificações etiológicas de anovulação e amenorreia secundária, junto com a atualização de cada uma dessas causas, a fim de selecionar a classificação que as agrupe integralmente para focar o manejo de forma fácil e prática. Para isso, foi revisada a literatura médica recente em textos consultados em PubMed, Ovid, Clinical guidelines e Cochrane library, a partir de palavras-chave. Conclui-se que a classificação etiológica integral em cinco compartimentos é um guia fácil de seguir para obter o diagnóstico de cada uma dessas causas, atualmente, quando existem medicamentos e procedimentos cirúrgicos seguros para manejá-las como anovulação ou como amenorreia secundária.
dc.formatapplication/pdf
dc.formattext/xml
dc.languagespa
dc.publisherUniversidad Militar Nueva Granada
dc.relationhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/4853/4630
dc.relationhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/4853/4786
dc.relation/*ref*/Pérez LE, editor. Infertilidad y Endocrinología Reproductiva. Cuarta edición. Bogotá (Colombia): Brand Studio; 2015. Regulación neuroendocrinopsicoinmunológica del ciclo menstrual. p. 15-32.
dc.relation/*ref*/Taylor H S, Pal L, Seli E. Amenorrhea. En: Speroff's L, editor. Clinical Ginecology Endodocrinology and Infertility. 9a ed. Philadelfia-Baltimor, New York, London, Buenos Aires, Hong Kong, Sydney, Tokio: Wolters Cluwer; 2020. p. 821-939.
dc.relation/*ref*/Jaimes H, Sepúlveda J. Amenorrea primaria. En: Pérez LE, editor. Infertilidad y Endocrinología Reproductiva. Cuarta edición. Bogotá (Colombia): Brand Studio; 2015. p. 153-167.
dc.relation/*ref*/ESHRE Capri Workshop Group. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update [Internet]. 2012;18(5):586-99. https://doi.org/10.1093/humupd/dms019
dc.relation/*ref*/Loret de Mola R. Amenorrhea [Internet] 27 ago. 2016. Disponible en: https://abdominalkey.com/amenorrhea/#bib3
dc.relation/*ref*/The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2008; 90(suppl3):219-25. https://doi.org/10.1016/j.fertnstert.2008.08.038
dc.relation/*ref*/Protoloco SEGO. Amenorrea primaria y secundaria [Internet]. 2013;56(7):387-392. Disponible en: https://www.elsevier.es/es-revista-progresos-obstetricia-ginecologia-151-articulo-protoloco-sego-amenorrea-primaria-secundaria--S0304501313000988. https://doi.org/10.1016/j.pog.2013.04.006
dc.relation/*ref*/Rebar RW. Assessment of the female patient. En: Carr BR, Blackwell RE, editores. Textbook of reproductive Medicine. Norwalk USA: Appleton & Lange; 1993. p. 247-63.
dc.relation/*ref*/Pérez LE. Amenorrea secundaria. En: Fecolsog, editor. Texto de Obstetricia y Ginecología. 2a ed. Bogotá (Colombia): Alta voz; 2010. p. 727-732.
dc.relation/*ref*/Pérez LE., editor. Infertilidad y Endocrinología Reproductiva. 2a ed. Bogotá (Colombia): Hospital Militar Central; 2000. Anovulación, oligomenorreas, amenorreas y hemorragia uterina disfuncional. p. 128-143.
dc.relation/*ref*/Pérez LE, editor. Infertilidad y Endocrinología Reproductiva. 3a ed. Barranquilla (Colombia): Grafimpresos; 2007. Anovulación y amenorrea secundaria. 169-184.
dc.relation/*ref*/Pérez LE, editor. Infertilidad y endocrinología reproductiva. 4a ed. Bogotá (Colombia): Universidad Militar Nueva Granada, Brand studio; 2015. Amenorrea secundaria y anovulación. 169-184.
dc.relation/*ref*/Mancini F, Martínez M, Tur R. Guía 6. Estudio y tratamiento de las amenorreas hipotalamohipofisarias. Hospital Universitario Quirón Dexeus [Internet]. Disponible en: https://www.sefertilidad.net/docs/biblioteca/guiasPracticaClinicas/guia6.pdf
dc.relation/*ref*/Vale B, Brito S, Paulos L, Moleiro P. Menstruation disorders in adolescents with eating disorders - target body mass index percentiles for their resolution. Einstein (São Paulo) [Internet]. 2017;12(2):175-180. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/25003922. https://doi.org/10.1590/S1679-45082014AO2942
dc.relation/*ref*/Ackerman KE, Misra M. Amenorrhea in adolescent female athletes. Lancet Child Adolescent Health. 2018;2(9):677-688. https://doi.org/10.1016/S2352-4642(18)30145-7
dc.relation/*ref*/Kigawa M, Harada M, Kawahara T, Osuga Y, Saito S. Low bone mineral density in elite female athletes with a history of secondary amenorrhea in their teens. Clin J Sport Med. Clin J Sport Med. May. 2020;30(3):245-250. https://doi.org/10.1097/JSM.0000000000000571
dc.relation/*ref*/Shufelt CL, Torbati T, Dutra E. Hypothalamic amenorrhea and the long-term health consequences. Semin Reprod Med. 2017;35(3):256-262. https://doi.org/10.1055/s-0037-1603581
dc.relation/*ref*/Vilar L, Vilar CF, Lyra R, Freitas MDC. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinol. 2019;109(1):7-19. https://doi.org/10.1159/000499694
dc.relation/*ref*/Eren E, Törel Ergür A, İşgüven ŞP, Çelebi Bitkin E, Berberoğlu M, Şıklar Z, Baş F et al. Laboratory Characteristics of Hyperprolactinemia. DJ Clin Res [Internet]. 2019 may. 28;11(2):149-156. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/30396878. https://doi.org/10.4274/jcrpe.galenos.2018.2018.0206
dc.relation/*ref*/Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. https://doi.org/10.1038/nrendo.2018.24
dc.relation/*ref*/Castro E. Síndrome de ovario poliquístico. En: Pérez LE, editor. Infertilidad y endocrinología reproductiva. 4a ed. Bogotá (Colombia): Universidad Militar Nueva Granada, Brand studio; 2015. Pp. 217-243.
dc.relation/*ref*/Pasquali R, Gambineri A. New perspectives on the definition and management of polycystic ovary syndrome. J Endocrinol Invest. 2018; 41(10):1123-1135. https://doi.org/10.1007/s40618-018-0832-1
dc.relation/*ref*/Raperport C, Homburg R. The Source of Polycystic Ovarian Syndrome. Clin Med Insights Reprod Health. 2019;13:1179-1198. https://doi.org/10.1177/1179558119871467
dc.relation/*ref*/Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 oct.;7(5):467-520. https://doi.org/10.1210/er.2015-1104
dc.relation/*ref*/Jeanes YM, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017;30(1):97-105. https://doi.org/10.1017/S0954422416000287
dc.relation/*ref*/Jacob S, Balen A. How will the new global polycystic ovary syndrome guideline change our clinical practice? Clin Med Insights Reprod Health. 2019 jun.;13:1-7. https://doi.org/10.1177/1179558119849605
dc.relation/*ref*/Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017;11:CD003053. https://doi.org/10.1002/14651858.CD003053.pub6
dc.relation/*ref*/Kim CH, Chon SJ, Lee SH. Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis. Sci Rep. 2020;10(1):7802. https://doi.org/10.1038/s41598-020-64776-w
dc.relation/*ref*/Wang R, Kim BV, van Wely M, Johnson NP, Costello MF, Zhang H et al. Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis. BMJ. 2017 en. 31;356:1-11. https://doi.org/10.1136/bmj.j138
dc.relation/*ref*/Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2018 may. 24; 5:CD010287. https://doi.org/10.1002/14651858.CD010287.pub3
dc.relation/*ref*/Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil Steril. 2019 mar.;111(3):571-578. https://doi.org/10.1016/j.fertnstert.2018.11.030
dc.relation/*ref*/Costello MF, Misso ML, Balen A, Boyle J, Devoto L, Garad RM et al. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2019 sep. 12;59(6). https://doi.org/10.1111/ajo.13051
dc.relation/*ref*/Teede H, Misso M, Costello M et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018 ag.;110(3):364-379. https://doi.org/10.1016/j.fertnstert.2018.05.004
dc.relation/*ref*/Barreda-Velit C1, Salcedo-Pereda R, Ticona J. Schmidt's syndrome: a difficult diagnosis in the Latin American context. Rev Med Inst Mex Seguro Soc. 2018; 56(2):189-193.
dc.relation/*ref*/South Med J. 2017 Mar; 110 (3):147-153. Primary Ovarian Insufficiency: Current Concepts. Collins G1, Patel B1, Thakore S1, Liu J. https://doi.org/10.14423/SMJ.0000000000000611
dc.relation/*ref*/Zhang X, Han T, Yan L, Jiao X, Qin Y, Chen ZJ. Resumption of ovarian function after ovarian biopsy/scratch in patients with premature ovarian insufficiency. Reprod Sci. 2019 feb.;26(2):207-213. https://doi.org/10.1177/1933719118818906
dc.relation/*ref*/Cho K, Havelock JC, Gilks B, Dunne C. Case report: an identical twin with Sertoli-Leydig cell tumor. Gynecol Endocrinol. 2018 en. 24;34(7):563-566. https://doi.org/10.1080/09513590.2018.1431215
dc.relation/*ref*/Sehemby M, Bansal B, Sarathi V, Kolhe A, Kothari K, Jadhav-Ramteke S el al. Virilising ovarian tumors: a single-center experience. Endocr Connect. 2018;7(12):1362-1369. https://doi.org/10.1530/EC-18-0360
dc.relation/*ref*/LaVoie M, Constantinides V, Robin N, Kyriacou A. Florid hyperandrogenism due to a benign adrenocortical adenoma. BJM Case Rep. 2018 jul. 30;bcr2018224804. https://doi.org/10.1136/bcr-2018-224804
dc.relation/*ref*/Poppe K. Velkeniers B. Thyroid disorders in infertile women. Ann Endocrinol. 2003;64(1):45-50
dc.relation/*ref*/Gronier H, Sonigo C, Jacquesson L. Impact of thyroid function on fertility. Gynecol Obstet Fertil. 2015 mar.;43(3):225-33. https://doi.org/10.1016/j.gyobfe.2015.01.005
dc.relation/*ref*/Burdea L, Mendez MD. 21 Hydroxylase Deficiency. StatPearls [Internet] 2020 mar. 24 [revisión 2020 abr. 20]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29630216
dc.relation/*ref*/Pérez LE, editor. Infertilidad y endocrinología reproductiva. 4a ed. Bogotá (Colombia): Universidad Militar Nueva Granada, Brand studio; 2015. Hiperplasia suprarrenal; 267-279.
dc.relation/*ref*/Barnett R. Cushing's syndrome. Lancet [Internet]. 2016 jul. 31 [revision 2020 may. 17];388(10045):649. Disponible en https://europepmc.org/article/med/27551694. https://doi.org/10.1016/S0140-6736(16)31280-6
dc.relation/*ref*/Feelders RA, Newell-Price J, Pivonello R, Nieman LK, Hofland LJ, Lacroix A. Advances in the medical treatment of Cushing's syndrome. Lancet Diabetes Endocrinol. 2019 abr.;7(4):300-312. https://doi.org/10.1016/S2213-8587(18)30155-4
dc.relation/*ref*/Klibansky, A. Pregnancy after cure of Cushing's disease. Cushin's Support & Research Foundation CSRF [Internet]. 2006 dic. 12. Disponible en: https://csrf.net/doctors-articles/reproductive-issues/pregnancy-after-cure-of-cushings-disease/
dc.relation/*ref*/Baradwan S, Baradwan A, Al-Jaroudi D. The association between menstrual cycle pattern and hysteroscopic march classification with endometrial thickness among infertile women with Asherman syndrome. Medicine (Baltimore). 2018;97(27):e11314. https://doi.org/10.1097/MD.0000000000011314
dc.relation/*ref*/Mutiso SK, Oindi FM, Hacking N, Obura T. Uterine Necrosis after Uterine Artery Embolization for Symptomatic Fibroids. Case Rep Obstet Gynecol. 2018; 2018:9621741. https://doi.org/10.1155/2018/9621741
dc.relation/*ref*/Nobuhiko S, Ayako Hayashi, Iori Kisu, Kouji Banno, Hisako Hara, Makoto Mihara. Uterus transplantation: Toward clinical application in Japan. Reprod Med Biol. 2017;16(4): 305-313. https://doi.org/10.1002/rmb2.12048
dc.relation/*ref*/Salgado S. Análisis de hormonas femeninas en el estudio de fertilidad. Ovodonante [Internet]. 2016 nov. 21. Disponible en: https://ovodonante.com/analisis-de-hormonas-femeninas-en-el-estudio-de-fertilidad/
dc.relation/*ref*/Medilineplus.gov Medida de cortisol en orina. Mediplus Medical encyclopedia. 6 may. 2019 [Internet]. Disponible en: https://medlineplus.gov/spanish/ency/article/003703.htm
dc.rightsDerechos de autor 2021 Revista Med
dc.sourceRevista Med; Vol. 28 No. 2 (2020): july - december; 85-102
dc.sourceRevista Med; Vol. 28 Núm. 2 (2020): julio - diciembre; 85-102
dc.source1909-7700
dc.source0121-5256
dc.titleAnovulation and secondary amenorrhea: easy and practical approach
dc.titleAnovulación y amenorrea secundaria: enfoque fácil y práctico
dc.titleAnovulação e amenorreia secundária: abordagem fácil e prática
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución